SHANGHAI & CAMBRIDGE, Mass. / Oct 18, 2024 / Business Wire / Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in November and December 2024:
Goldman Sachs APAC Healthcare Corporate Day 2024
Time: November 5-8, 2024
Location: Hong Kong, Hong Kong
Jefferies London Healthcare Conference
Fireside Chat: Tuesday, November 19, 2024,1:30 p.m. GT
Location: Aldwych, London
Citi's 2024 Global Healthcare Conference
Time: December 3-5, 2024
Location: Miami, Florida
About Zai Lab
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide.
For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.
| Last Trade: | US$38.03 |
| Daily Change: | 1.89 5.23 |
| Daily Volume: | 784,391 |
| Market Cap: | US$4.140B |
February 27, 2025 January 22, 2025 January 17, 2025 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
